Skip to main content

Table 1 Baseline characteristics of 268 HIV patients at time of initiation of antiretroviral therapy randomized to lipid-based nutrient supplements or no supplements

From: Effects of nutritional supplementation on glucose metabolism and insulin function among people with HIV initiating ART

Characteristics Non-supplemented (n = 89)a Supplemented (n = 179)a
Age (years) 32 ± 9 33 ± 9
Women, n (%) 63 (70.8) 117 (65.4)
Educational status
 No schooling, n (%) 27 (30.3) 40 (22.4)
 Primary education, n (%) 44 (49.4) 103 (57.5)
 Secondary and higher education, n (%) 18 (20.2) 36 (20.1)
Body mass index (kg/m2) 19.8 ± 2.1 19.9 ± 2.3
Weight (kg) 51.4 ± 7.3 54.2 ± 7.4
Waist circumference (cm) 71.9 ± 6.7 73.0 ± 6.5
C-reactive protein (mg/L)b 2.1 (0.6–7.5) 1.6 (0.5–5.5)
HIV-related characteristics
 WHO stage
  Stage I, n (%) 25 (28.4) 61 (34.1)
  Stage II, n (%) 26 (29.6) 58 (32.4)
  Stage III, n (%) 29 (33.0) 44 (24.6)
  Stage IV, n (%) 8 (9.1) 16 (8.9)
 HIV viral load (log (1+ copies/mL)) 4.7 ± 0.8 4.8 ± 0.8
 CD4 count (cells/μl) 191 ± 107 185 ± 101
 CD8 count (cells/μl) 878 ± 416 871 ± 426
  1. Abbreviations: HIV Human immunodeficiency virus, LNS Lipid-based nutrient supplements, WHO World Health Organization
  2. aData are means (±Standard deviation) or number (%)
  3. bData presented with median with interquartile range